Medium-chain triglycerides improve cognition and systemic metabolism in mouse models of Alzheimer’s disease - Poll - MDSpire

Medium-chain triglycerides improve cognition and systemic metabolism in mouse models of Alzheimer’s disease

  • By

  • Paule E H M’Bra

  • Laura K Hamilton

  • Gaël Moquin-Beaudry

  • Chenicka L Mangahas

  • Federico Pratesi

  • Anne Castonguay

  • Sophia Mailloux

  • Manon Galoppin

  • Jessica Avila Lopez

  • Megan Bernier

  • Marta Turri

  • Marian Mayhue

  • Anne Aumont

  • Martine Tetreault

  • Stephen C Cunnane

  • Karl J L Fernandes

  • August 6, 2025

  • 0 min

Share

Original Source(s)

Medium-chain triglycerides improve cognition and systemic metabolism in mouse models of Alzheimer’s disease

  • by Paule E H M’Bra, Laura K Hamilton, Gaël Moquin-Beaudry, Chenicka L Mangahas, Federico Pratesi, Anne Castonguay, Sophia Mailloux, Manon Galoppin, Jessica Avila Lopez, Megan Bernier, Marta Turri, Marian Mayhue, Anne Aumont, Martine Tetreault, Stephen C Cunnane, Karl J L Fernandes

  • August 6, 2025

Related Content

A Narrative Review: Do Systemic Drugs Used in the Treatment of Psoriatic Disease Affect Alzheimer’s Disease?

Neuroinflammation in Alzheimer’s disease: glial crosstalk, pathological modulation, and therapeutic implications

Electroacupuncture for treating the cognitive symptoms of Alzheimer’s disease: a randomized controlled trial